Share Twitter LinkedIn Facebook Email Hope Rugo, M.D., University Of California San Francisco discusses EMBRACA Trial, Sensoring Process, QOL. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
Enhertu DESTINY-Breast06 Phase III Study the Impact on HR-Positive, HER2-Low Metastatic Breast Cancer Revealed Breast 4 Mins Read
Strategizing Personalized Breast Cancer Treatment: A Promising Overview of Advances and Clinical Applications [39 SLIDES] Breast 4 Mins Read